FDA warns of ‘PERMANENT VISION LOSS’ linked to popular GLP-1 drugs

FOX Business' Taylor Riggs reports on new FDA safety warnings for GLP-1 medications like Wegovy and Ozempic. The agency warns of a rare but serious risk of permanent vision loss from an eye condition.

The FDA mandates new safety warnings for popular GLP-1 weight-loss drugs including Wegovy, Ozempic and Mounjaro. Taylor Riggs reports on the rare but serious risk of permanent vision loss from an eye condition.